Clinical Investigation of the Clareon® Intraocular Lens (IOL)
Public ClinicalTrials.gov record NCT03170154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Investigation of the Clareon® IOL
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to compare visual acuity and adverse event outcomes from the Clareon intraocular lens (IOL) to historical safety and performance endpoint (SPE) rates.
Study identification
- NCT ID
- NCT03170154
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 376 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2017 (Actual)
- Primary completion
- Feb 15, 2019 (Actual)
- Completion
- Feb 15, 2019 (Actual)
- Last update posted
- Aug 3, 2020
2017 – 2019
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alcon Investigative Site | Fresno | California | 93720 | — |
| Alcon Investigative Site | Sacramento | California | 95815 | — |
| Alcon Investigative Site | San Leandro | California | 94578 | — |
| Alcon Investigative Site | Deerfield Beach | Florida | 33064 | — |
| Alcon Investigative Site | Orland Park | Illinois | 60467 | — |
| Alcon Investigative Site | Bloomfield Hills | Michigan | 48302 | — |
| Alcon Investigative Site | Kansas City | Missouri | 64154 | — |
| Alcon Investigative Site | New York | New York | 10013 | — |
| Alcon Investigative Site | Poughkeepsie | New York | 12603 | — |
| Alcon Investigative Site | Elizabeth City | North Carolina | 27909 | — |
| Alcon Investigative Site | Southern Pines | North Carolina | 28387 | — |
| Alcon Investigative Site | Florence | South Carolina | 29501 | — |
| Alcon Investigative Site | Ladson | South Carolina | 29456 | — |
| Alcon Investigative Site | Austin | Texas | 78731 | — |
| Alcon Investigative Site | Nacogdoches | Texas | 75965 | — |
| Alcon Investigative Site | Appleton | Wisconsin | 54914 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03170154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03170154 live on ClinicalTrials.gov.